Phase 2 Migraine trials recruiting now

All Migraine trials, every phase

Other phases for Migraine

Phase 2 Migraine trials

• A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
  NCT06625060 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 166 locations
• A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
  NCT06602479 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 54 locations
• Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura
  NCT04063540 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 10 locations
• Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
  NCT07061847 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Cabergoline for Episodic Migraine
  NCT07072910 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial
  NCT05337033 · Phase: Phase 2 · Ages: 14 Years to 17 Years · Sex: All (male and female) · 3 locations
• Cannabis for the Prophylactic Treatment of Migraine
  NCT03972124 · Phase: Phase 2 · Ages: 25 Years and older · Sex: All (male and female) · 1 location
• Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
  NCT04930887 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Efficacy of Nerve Blocks for Episodic Migraine
  NCT05734625 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults
  NCT07304518 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)
  NCT06485336 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 6 locations
• Prophylactic Treatment With Atorvastatin for Episodic Migraine.
  NCT06248671 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 6 locations
• Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
  NCT07646613 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 6 locations
• Study of EVO756 in Adults With Migraine
  NCT07616128 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 26 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.